Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
50–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Well-demarcated area of GA secondary to AMD
Women of childbearing potential and men must agree to use adequate contraception for at least 30 days after fluorescein dye administration
The study is recruiting participants in two different cohorts:
Cohort 1: Participants with unilateral GA OR Cohort 2: Participants with GA in one eye and CNV (active or treated) with or without GA, in the contralateral eye
You may not be if
Previous participation in any studies of investigational drugs for GA / dry AMD (exception for studies of vitamins and minerals)
GA in either eye due to causes other than AMD
History of vitrectomy surgery, submacular surgery, or any surgical intervention for AMD
Any ocular/systemic medical conditions that, in the opinion of the investigator, could contribute to participant's inability to participate in the study or interfere with study assessments.
Requirement for continuous use of therapy indicated in Prohibited Therapy
